CN100528164C - 用于增强认知保养的抑制素产品 - Google Patents
用于增强认知保养的抑制素产品 Download PDFInfo
- Publication number
- CN100528164C CN100528164C CNB038073854A CN03807385A CN100528164C CN 100528164 C CN100528164 C CN 100528164C CN B038073854 A CNB038073854 A CN B038073854A CN 03807385 A CN03807385 A CN 03807385A CN 100528164 C CN100528164 C CN 100528164C
- Authority
- CN
- China
- Prior art keywords
- statin
- inhibin
- galantamine
- galanthamine
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36928502P | 2002-04-02 | 2002-04-02 | |
| US60/369,285 | 2002-04-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1642555A CN1642555A (zh) | 2005-07-20 |
| CN100528164C true CN100528164C (zh) | 2009-08-19 |
Family
ID=28675573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB038073854A Expired - Fee Related CN100528164C (zh) | 2002-04-02 | 2003-03-28 | 用于增强认知保养的抑制素产品 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1492539B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005525391A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100986194B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100528164C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE331523T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003226753B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0308293A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2480275C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1105545T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60306503T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1492539T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA013069B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2268393T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL164317A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04009535A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20044698L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ536111A (cg-RX-API-DMAC7.html) |
| PL (1) | PL211160B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1492539E (cg-RX-API-DMAC7.html) |
| UA (1) | UA79605C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003082298A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| EP1737539A1 (en) * | 2004-04-14 | 2007-01-03 | Warner-Lambert Company LLC | Therapeutic combination for treatment of alzheimers disease |
| EP1604686A1 (en) * | 2004-06-08 | 2005-12-14 | Axonyx, Inc. | Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression |
| GB0607946D0 (en) * | 2006-04-21 | 2006-05-31 | Minster Res The Ltd | Mono and combination therapy |
| AU2007299726A1 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| US20160303146A1 (en) * | 2013-12-13 | 2016-10-20 | David A. TABACZYNSKI | Inhibition of isoprenoid biosynthetic pathways to treat neuroinflammatory disorders |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1222077A (zh) * | 1996-06-14 | 1999-07-07 | 詹森药业有限公司 | 快速溶出的雪花胺氢溴酸盐片剂 |
-
2003
- 2003-03-28 DK DK03745196T patent/DK1492539T3/da active
- 2003-03-28 BR BR0308293-8A patent/BR0308293A/pt not_active IP Right Cessation
- 2003-03-28 KR KR1020047013127A patent/KR100986194B1/ko not_active Expired - Fee Related
- 2003-03-28 UA UA20040806803A patent/UA79605C2/uk unknown
- 2003-03-28 EA EA200401295A patent/EA013069B1/ru not_active IP Right Cessation
- 2003-03-28 IL IL16431703A patent/IL164317A0/xx unknown
- 2003-03-28 DE DE60306503T patent/DE60306503T2/de not_active Expired - Lifetime
- 2003-03-28 ES ES03745196T patent/ES2268393T3/es not_active Expired - Lifetime
- 2003-03-28 MX MXPA04009535A patent/MXPA04009535A/es active IP Right Grant
- 2003-03-28 CN CNB038073854A patent/CN100528164C/zh not_active Expired - Fee Related
- 2003-03-28 AT AT03745196T patent/ATE331523T1/de active
- 2003-03-28 CA CA2480275A patent/CA2480275C/en not_active Expired - Fee Related
- 2003-03-28 PT PT03745196T patent/PT1492539E/pt unknown
- 2003-03-28 JP JP2003579835A patent/JP2005525391A/ja active Pending
- 2003-03-28 WO PCT/EP2003/003324 patent/WO2003082298A1/en not_active Ceased
- 2003-03-28 EP EP03745196A patent/EP1492539B1/en not_active Expired - Lifetime
- 2003-03-28 PL PL371551A patent/PL211160B1/pl unknown
- 2003-03-28 NZ NZ536111A patent/NZ536111A/xx not_active IP Right Cessation
- 2003-03-28 AU AU2003226753A patent/AU2003226753B2/en not_active Ceased
-
2004
- 2004-09-28 IL IL164317A patent/IL164317A/en not_active IP Right Cessation
- 2004-10-29 NO NO20044698A patent/NO20044698L/no not_active Application Discontinuation
-
2006
- 2006-09-27 CY CY20061101397T patent/CY1105545T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1222077A (zh) * | 1996-06-14 | 1999-07-07 | 詹森药业有限公司 | 快速溶出的雪花胺氢溴酸盐片剂 |
Non-Patent Citations (1)
| Title |
|---|
| Statins and the risk of dementia. H. JICK ET AL.The LANCET,Vol.356 No.9242. 2000 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL211160B1 (pl) | 2012-04-30 |
| PT1492539E (pt) | 2006-11-30 |
| KR100986194B1 (ko) | 2010-10-07 |
| DE60306503T2 (de) | 2007-06-21 |
| DK1492539T3 (da) | 2006-10-30 |
| PL371551A1 (en) | 2005-06-27 |
| CY1105545T1 (el) | 2010-07-28 |
| IL164317A0 (en) | 2005-12-18 |
| AU2003226753B2 (en) | 2007-06-28 |
| AU2003226753A1 (en) | 2003-10-13 |
| NZ536111A (en) | 2006-03-31 |
| NO20044698L (no) | 2004-10-29 |
| ATE331523T1 (de) | 2006-07-15 |
| EA200401295A1 (ru) | 2005-02-24 |
| DE60306503D1 (de) | 2006-08-10 |
| HK1079688A1 (zh) | 2006-04-13 |
| JP2005525391A (ja) | 2005-08-25 |
| CN1642555A (zh) | 2005-07-20 |
| MXPA04009535A (es) | 2005-01-25 |
| EP1492539B1 (en) | 2006-06-28 |
| UA79605C2 (en) | 2007-07-10 |
| EP1492539A1 (en) | 2005-01-05 |
| ES2268393T3 (es) | 2007-03-16 |
| BR0308293A (pt) | 2004-12-28 |
| KR20040096608A (ko) | 2004-11-16 |
| IL164317A (en) | 2010-04-29 |
| EA013069B1 (ru) | 2010-02-26 |
| CA2480275C (en) | 2011-08-16 |
| WO2003082298A1 (en) | 2003-10-09 |
| CA2480275A1 (en) | 2003-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lechin et al. | Pimozide therapy for trigeminal neuralgia | |
| EP3329909B1 (en) | Fenfluramine for use in the treatment of dravet syndrome | |
| US20170042878A1 (en) | Compositions comprising scopolamine and ketamine in the treatment of depression | |
| US20080004284A1 (en) | Method for treating fibromyalgia syndrome and related conditions | |
| JP2023523706A5 (cg-RX-API-DMAC7.html) | ||
| WO2007116074A1 (en) | Trimetazidine for use in the treatment of fibromyalgia syndrome and related conditions | |
| AU780817B2 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
| KR100986194B1 (ko) | 인지능 유지 향상을 위한 스타틴 요법 | |
| CN109069466A (zh) | 5-ht6受体拮抗剂用于治疗阿尔茨海默病伴情感淡漠共病 | |
| RU2535019C1 (ru) | Седативное и спазмолитическое средство | |
| Grama et al. | Effect of caffeine on pain management | |
| CN101028265A (zh) | 一种改善睡眠调整睡醒节律的黑白药物组合物 | |
| EP0440851A1 (en) | Use of buspirone for the treatment of depressions | |
| US20050222122A1 (en) | Statin therapy for enhancing cognitive maintenance | |
| HK1079688B (en) | Statin product for enhancing cognitive maintenance | |
| HK40112834A (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| WO2023036820A1 (en) | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine | |
| JPH03246225A (ja) | メランコリーうつ病の治療法 | |
| HK1256346B (en) | Fenfluramine for use in the treatment of dravet syndrome | |
| HK1256346A1 (en) | Fenfluramine for use in the treatment of dravet syndrome | |
| Spector | A Skeptic’s View of Pharmaceutical Progress | |
| Elliott et al. | Galantamine HBr Tablets (Reminyl—Janssen Pharmaceutica) | |
| Elliott et al. | Pharmacology Update: Memantine Hydrochloride Tablets (Namenda) | |
| VLESSIDES | Depression Not Well Managed in Fibromyalgia | |
| Do | New Insomnia Medication is More of the Same: Limited Efficacy With Serious Safety Concerns |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1079688 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1079688 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090819 Termination date: 20210328 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |